XAIR Stock Summary and Trading Ideas (Beyond Air | NASDAQ:XAIR)

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Beyond Air trades on the NASDAQ stock market under the symbol XAIR.

As of December 24, 2025, XAIR stock price declined to $0.82 with 99,353 million shares trading.

XAIR has a beta of 0.14, meaning it tends to be less sensitive to market movements. XAIR has a correlation of 0.00 to the broad based SPY ETF.

XAIR has a market cap of $6.54 million. This is considered a Sub-Micro Cap stock.

Last quarter Beyond Air reported $2 million in Revenue and -$1.25 earnings per share. This fell short of revenue expectation by $-718,330 and missed earnings estimates by -$.65.

In the last 3 years, XAIR traded as high as $154.80 and as low as $.80.

The top ETF exchange traded funds that XAIR belongs to (by Net Assets): VTI, VXF.

XAIR has underperformed the market in the last year with a price return of -90.7% while the SPY ETF gained +17.3%. XAIR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -64.7% and -29.0%, respectively, while the SPY returned +4.4% and +1.4%, respectively.

XAIR support price is $.80 and resistance is $.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XAIR shares will trade within this expected range on the day.